Anti-EGFR Antibody Cetuximab Enhances the Cytolytic Activity of Natural Killer Cells toward Osteosarcoma

Author(s):
Pahl, J.H.W.; Ruslan, S.E.N.; Buddingh, E.P.; Santos, S.J.; Szuhai, K. (0000-0002-1228-4245); Serra, M.; Gelderblom, H.; Hogendoorn, P.C.W. (0000-0002-1513-8104); Egeler, R.M.; Schilham, M.W. (0000-0003-4391-6003); Lankester, A.C.
Published
2012
Publication type
Article / Letter to editor
Date issued
2012-01-15
Language
English
Is part of
Clinical Cancer Research (2012), Vol. 18, no. 2, p. 432-441
hdl
1887/99966
doi
10.1158/1078-0432.CCR-11-2277